---
figid: PMC4484825__gr1
figlink: /pmc/articles/PMC4484825/figure/f0005/
number: Fig. 1
caption: 'Patritumab and HER3 signaling pathway. (A) Binding of the ligand heregulin
  to HER3 induces a conformational change that allows for receptor dimerization of
  HER3 with HER family receptors, such as EGFR or HER2. (B) Heterodimerization initiates
  the transphosphorylation of HER3 at specific tyrosine residues by the kinase of
  its heterodimeric partner. (C) The phosphorylated tyrosine kinase residues create
  6 direct docking sites for PI3K, leading to the activation of other molecules further
  downstream in the PI3K–Akt pathway. EGFR: epidermal growth factor receptor; HER:
  human epidermal growth factor receptor; PI3K: phosphatidylinositol-3-kinase.'
pmcid: PMC4484825
papertitle: Clinical Translation and Validation of a Predictive Biomarker for Patritumab,
  an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in
  Patients With Advanced Non-small Cell Lung Cancer.
reftext: Jeanne Mendell, et al. EBioMedicine. 2015 Mar;2(3):264-271.
pmc_ranked_result_index: '39654'
pathway_score: 0.9374528
filename: gr1.jpg
figtitle: Patritumab and HER3 signaling pathway
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4484825__gr1.html
  '@type': Dataset
  description: 'Patritumab and HER3 signaling pathway. (A) Binding of the ligand heregulin
    to HER3 induces a conformational change that allows for receptor dimerization
    of HER3 with HER family receptors, such as EGFR or HER2. (B) Heterodimerization
    initiates the transphosphorylation of HER3 at specific tyrosine residues by the
    kinase of its heterodimeric partner. (C) The phosphorylated tyrosine kinase residues
    create 6 direct docking sites for PI3K, leading to the activation of other molecules
    further downstream in the PI3K–Akt pathway. EGFR: epidermal growth factor receptor;
    HER: human epidermal growth factor receptor; PI3K: phosphatidylinositol-3-kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ERBB3
  - PIK3CB
  - PIK3R4
  - PIK3R3
  - PIK3R6
  - PIK3R5
  - AKT1
  - AKT3
  - PIK3CA
  - AKT2
  - PIK3CD
  - PIK3CG
genes:
- word: HER3
  symbol: HER3
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals: []
diseases: []
---
